Your browser doesn't support javascript.
loading
Anorectal mucosal melanoma.
Alvarez, Janet; Smith, J Joshua.
Affiliation
  • Alvarez J; Research Scholar, Memorial Sloan Kettering Cancer Center, Department of Surgery, 1275 York Avenue | SR-201, New York, NY 10065, USA.
  • Smith JJ; Associate Member, Associate Attending Surgeon, Memorial Sloan Kettering Cancer Center, Colorectal Service, Department of Surgery, 1275 York Avenue, SR-201, New York, NY 10065, USA.
Semin Colon Rectal Surg ; 34(4)2023 Dec.
Article in En | MEDLINE | ID: mdl-38746826
ABSTRACT
Anorectal mucosal melanoma accounts for less than 1 % of all anorectal malignant tumors and a tendency for delayed diagnosis leads to advanced disease at presentation.1,2 Due to the rarity of the disease, there are limited prospective trials exploring the optimal treatment strategies. Generally, tumors are surgically excised, with a preference for conservative management with wide local excision. In the past decade, there have been advances with immunotherapy and other targeted therapies. Multiple clinical trials continue exploring neoadjuvant/adjuvant combination treatments in the setting of advanced or unresectable disease.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Semin Colon Rectal Surg Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Semin Colon Rectal Surg Year: 2023 Type: Article Affiliation country: United States